Pink Sheet Podcast: BrainStorm Withdraws NurOwn, NIH Nominee On Drug Pricing, Gene Therapy Long-Term Follow-Up
Executive Summary
Pink Sheet reporters and editor discuss BrainStorm’s next steps after withdrawing the NurOwn BLA, NIH director nominee Monica Bertagnolli’s thoughts on drug affordability, and the US FDA’s effort to ensure long-term follow-up of gene therapy patients.